U01PS001097/PS/NCHHSTP CDC HHS/United States[Grants and Funding] - Search Results

Save citations to file

Email citations

Your saved search

Your RSS Feed

Year	Number of Results
2012	1
2013	3
2025	0

Page 1

Duration of protection against hepatitis A for the current two-dose vaccine compared to a three-dose vaccine schedule in children.

Raczniak GA, Thomas TK, Bulkow LR, Negus SE, Zanis CL, Bruce MG, Spradling PR, Teshale EH, McMahon BJ. Raczniak GA, et al. Vaccine. 2013 Apr 19;31(17):2152-5. doi: 10.1016/j.vaccine.2013.02.048. Epub 2013 Mar 5. Vaccine. 2013. PMID: 23470239 Free PMC article.

Rates and risk factors for hepatitis B reactivation in a cohort of persons in the inactive phase of chronic hepatitis B-Alaska, 2001-2010.

Tohme RA, Bulkow L, Homan CE, Negus S, McMahon BJ. Tohme RA, et al. J Clin Virol. 2013 Oct;58(2):396-400. doi: 10.1016/j.jcv.2013.08.012. Epub 2013 Aug 16. J Clin Virol. 2013. PMID: 24001884 Free PMC article.

Long-term immunogenicity of hepatitis A virus vaccine in Alaska 17 years after initial childhood series.

Raczniak GA, Bulkow LR, Bruce MG, Zanis CL, Baum RL, Snowball MM, Byrd KK, Sharapov UM, Hennessy TW, McMahon BJ. Raczniak GA, et al. J Infect Dis. 2013 Feb 1;207(3):493-6. doi: 10.1093/infdis/jis710. Epub 2012 Nov 29. J Infect Dis. 2013. PMID: 23204169 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

3 results

Results by year

Search Page

Filters

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

3 results

Results by year